Cesar Garcia
Physician Assistant · Pharr, TXNPI 1912534819
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (58.6%), travel and lodging and education — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Medtronic at 53.3% of the total. Reporting peaked in 2023 at $5,291 and has fallen 84.9% since, to $801 in 2025. Among physician assistant clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 193 payments — averaging $46.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$5K
- Optinose US, Inc.$1K
- Novo Nordisk$526
- AstraZeneca$331
- Amgen$318
- Inspire Medical Systems, Inc.$300
- plus $1K from 15 others
What the payments were for
- Travel & lodging$3,53040%
- Food & beverage$5,21559%
- Education$1612%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 40 | $4,748 |
| Optinose US, Inc. | 34 | $1,470 |
| Novo Nordisk | 28 | $526 |
| AstraZeneca | 13 | $331 |
| Amgen | 16 | $318 |
| Inspire Medical Systems, Inc. | 5 | $300 |
| Regeneron Healthcare Solutions, Inc. | 7 | $169 |
| AbbVie | 8 | $159 |
| Lilly USA, LLC | 14 | $144 |
| Stryker | 2 | $132 |
| GSK | 6 | $128 |
| Otsuka America Pharmaceutical, Inc. | 5 | $105 |
| Phadia US Inc. | 2 | $91 |
| Dexcom, Inc. | 2 | $48 |
| Acclarent, Inc | 2 | $45 |
| Abbott | 2 | $39 |
| Olympus America Inc. | 2 | $38 |
| Orthofix Medical, Inc. | 1 | $35 |
| Astellas Pharma US Inc | 2 | $34 |
| Boston Scientific | 1 | $27 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NUVENT$1,717
- PROPEL$1,716
- Xhance$1,106
- EVENITY$125
- CLARIFIX CRYOTHERAPY DEVICE$120
- LATERA$120
- XPRESS ENT DILATION SYSTEM$120
- SINUVA$106
- VRAYLAR$103
How this compares
$8,907 in reported general payments places this provider in the 95th percentile of 8,308 physician assistant providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 40 | $40,047 |
| OzempicSemaglutide | 11 | $13,397 |
| MounjaroTirzepatide | 13 | $13,317 |
| JardianceEmpagliflozin | 12 | $13,021 |
| Xigduo XrDapaglifloz Propaned/Metformin | 11 | $10,654 |
| MyrbetriqMirabegron | 19 | $8,786 |
| Lagevrio (Eua)Molnupiravir | 16 | $6,350 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 33 | $880 |
| Atorvastatin Calcium | 68 | $703 |
| Ipratropium Bromide | 22 | $565 |
| FenofibrateFenofibrate Nanocrystallized | 14 | $559 |
| Ciprofloxacin Hcl | 115 | $553 |
| Levothyroxine Sodium | 40 | $462 |
| Dicyclomine Hcl | 41 | $448 |
| Rosuvastatin Calcium | 27 | $423 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga | $331 | $40,04740 claims |
| Novo NordiskOzempic | $526 | $13,39711 claims |
| Lilly USA, LLCMounjaro | $144 | $13,31713 claims |
| Astellas Pharma US IncMyrbetriq | $34 | $8,78619 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,308 physician assistant providers in Texas.
Other physician assistant in Pharr
- Cynthia TrickettDallas$1.3M
- Kristine KuceraMelissa$797K
- Selina SantosAustin$543K
- Matthew BrunoMcKinney$538K
- Brooke HodnickSouthlake$479K
- Holly GloverArlington$418K
- Kirk GautierAthens$416K
- Jaime RomanPlano$338K
- Michael WhiteDallas$276K
- Heidi JeffreysLubbock$259K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.